SCOPUS 정보 검색 플랫폼

Journal of Hepatology

Volumn 59, Issue 1, 2013, Pages 197-198

Use of TNFα antagonists in refractory AIH: Revealing the unforeseen

(4) Saitis, Asterios a Gatselis, Nikolaos a Zachou, Kalliopi a Dalekos, George N a

a UNIVERSITY OF THESSALY (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; CYCLOSPORIN; F ACTIN; IMMUNOGLOBULIN G; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CASE REPORT; CLINICAL PRACTICE; CYTOTOXIC T LYMPHOCYTE; EMPERIPOLESIS; ENTERITIS; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; INFECTIOUS COMPLICATION; INFORMED CONSENT; LABORATORY TEST; LETTER; LIVER BIOPSY; LOW DRUG DOSE; LYMPHOCYTE ACTIVATION; MEDICAL HISTORY; MONOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; ROSETTE FORMATION; SEROLOGY;

ANTIBODIES, MONOCLONAL; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879160349 PISSN: 01688278 EISSN: None Source Type: Journal
DOI: 10.1016/j.jhep.2013.02.029 Document Type: Letter

Times cited : (18)

References (10)

1
- 84874110062
- Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis
- C. Weiler-Normann, C. Schramm, A. Quaas, C. Wiegard, C. Glaubke, and N. Pannicke Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis J Hepatol 58 2013 529 534
- (2013) J Hepatol , vol.58 , pp. 529-534
- Weiler-Normann, C.¹ Schramm, C.² Quaas, A.³ Wiegard, C.⁴ Glaubke, C.⁵ Pannicke, N.⁶

2
- 84869869355
- TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression
- S. Iwamoto, M. Kido, N. Aoki, H. Nishiura, R. Maruoka, and A. Ikeda TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression Clin Immunol 146 2013 15 25
- (2013) Clin Immunol , vol.146 , pp. 15-25
- Iwamoto, S.¹ Kido, M.² Aoki, N.³ Nishiura, H.⁴ Maruoka, R.⁵ Ikeda, A.⁶

3
- 84875912781
- Autoimmune hepatitis: A comprehensive review
- R. Liberal, C.R. Grant, G. Mieli-Vergani, and D. Vergani Autoimmune hepatitis: a comprehensive review J Autoimmun 41 2013 126 139
- (2013) J Autoimmun , vol.41 , pp. 126-139
- Liberal, R.¹ Grant, C.R.² Mieli-Vergani, G.³ Vergani, D.⁴

4
- 84871206097
- Biologics-induced autoimmune diseases
- behalf of the BIOGEAS study group
- R. Perez-Alvarez, M. Pérez-de-Lis, M. Ramos-Casals, and on behalf of the BIOGEAS study group Biologics-induced autoimmune diseases Curr Opin Rheumatol 25 2013 56 64
- (2013) Curr Opin Rheumatol , vol.25 , pp. 56-64
- Perez-Alvarez, R.¹ Pérez-De-Lis, M.² Ramos-Casals, M.³

5
- 47149112922
- Simplified criteria for the diagnosis of autoimmune hepatitis
- E.M. Hennes, M. Zeniya, A.J. Czaja, A. Pares, G.N. Dalekos, and E.L. Krawitt Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 2008 169 176
- (2008) Hepatology , vol.48 , pp. 169-176
- Hennes, E.M.¹ Zeniya, M.² Czaja, A.J.³ Pares, A.⁴ Dalekos, G.N.⁵ Krawitt, E.L.⁶

6
- 84860389502
- Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients
- K. Zachou, N. Gatselis, G. Papadamou, E.I. Rigopoulou, and G.N. Dalekos Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients J Hepatol 55 2011 636 646
- (2011) J Hepatol , vol.55 , pp. 636-646
- Zachou, K.¹ Gatselis, N.² Papadamou, G.³ Rigopoulou, E.I.⁴ Dalekos, G.N.⁵

7
- 84860840330
- Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease
- C. van Casteren-Messidoro, G. Prins, A. van Tilburg, Z. Zelinkova, J. Schouten, and R. de Man Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease J Crohn Colitis 6 2012 630 631
- (2012) J Crohn Colitis , vol.6 , pp. 630-631
- Van Casteren-Messidoro, C.¹ Prins, G.² Van Tilburg, A.³ Zelinkova, Z.⁴ Schouten, J.⁵ De Man, R.⁶

8
- 80054725710
- Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate
- K. Subramaniam, S. Chitturi, M. Brown, and P. Pavli Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate Inflamm Bowel Dis 17 2011 E149 E150
- (2011) Inflamm Bowel Dis , vol.17
- Subramaniam, K.¹ Chitturi, S.² Brown, M.³ Pavli, P.⁴

9
- 0029112253
- Induction of apoptosis in mature T cells by tumour necrosis factor
- L. Zheng, G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo Induction of apoptosis in mature T cells by tumour necrosis factor Nature 377 1995 348 351
- (1995) Nature , vol.377 , pp. 348-351
- Zheng, L.¹ Fisher, G.² Miller, R.E.³ Peschon, J.⁴ Lynch, D.H.⁵ Lenardo, M.J.⁶

10
- 79957927386
- Anti-TNF therapy: Safety aspects of taking the risk
- H. Rosenblum, and H. Amital Anti-TNF therapy: safety aspects of taking the risk Autoimmun Rev 10 2011 563 568
- (2011) Autoimmun Rev , vol.10 , pp. 563-568
- Rosenblum, H.¹ Amital, H.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.